Catalyst Wire Dossier Catalyst Wire Dossier

Ledipasvir/sofosbuvir

Ledipasvir and sofosbuvir · Asegua Therapeutics LLC
Drug timelines are a Plus or Pro feature.

34 regulatory and trial events tracked for Ledipasvir/sofosbuvir, covering 2014-10-10 to 2023-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy [Phase 1, Phase 2]

See pricing